XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (2,402,211) $ (147,961)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 20,616 393
Preferred A stock issued to consultants 0 71,558
Amortization of right-to-use asset 6,237 0
Gain on settlement of notes payable (1,836) 0
Gain on settlement of accounts payable 0 (42,292)
Gain (Loss) on revaluation of derivative liabilities 493,455 (496,369)
Derivative expense 0 36,433
Amortization of discount on notes payable 756,795 98,278
Stock based compensation 232,430 48,428
Changes in assets and liabilities:    
Prepaid expenses (14,618) 0
Inventory (1,480) 0
Accrued liabilities (366,636) 879
Operating lease liability 9,726 0
Due to related parties 0 2,000
Other current liabilities 880 0
Accrued interest 202,313 26,278
Net cash provided by (used in) operating activities (1,064,329) (402,375)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for acquisition of fixed assets (495,360) 0
Net cash used in investing activities (495,360) 0
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from private placement of common stock 1,668,000 0
Proceeds from sales of Series C Preferred Stock, net of fees 2,760,000 0
Proceeds from notes payable, net of payments to vendors 0 375,000
Principal payments on notes payable (177,534) (45,000)
Net cash provided by financing activities 4,250,466 330,000
Net increase (decrease) in cash and cash equivalents 2,690,777 (72,375)
Cash and cash equivalents at beginning of period 64,789 83,245
Cash and cash equivalents at end of period 2,755,566 10,870
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest paid 2,680 2,680
Income taxes paid 0 0
NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Stock issued for conversion of debt and accrued interest 2,653,795 0
Settlement of derivative liabilities (1,301,137) 231,323
Cashless exercise of warrants 0 50,986
Issued of Series A Preferred Stock to consultants 0 71,558
Preferred stock dividend 20,499 17,359
Derivative discounts 0 375,000
Conversion of Series A Preferred Stock to common stock 6,000 0
Deemed dividends on Preferred Stock $ 332,242 $ 0